When your daily work includes lots of document editing, you already know that every file format requires its own approach and often specific applications. Handling a seemingly simple MD file can sometimes grind the entire process to a halt, especially when you are trying to edit with insufficient software. To avoid this kind of problems, get an editor that can cover all of your needs regardless of the file extension and clean result in MD without roadblocks.
With DocHub, you will work with an editing multitool for just about any situation or file type. Reduce the time you used to spend navigating your old software’s features and learn from our intuitive user interface while you do the work. DocHub is a efficient online editing platform that handles all your file processing needs for virtually any file, including MD. Open it and go straight to efficiency; no prior training or reading manuals is required to enjoy the benefits DocHub brings to document management processing. Begin with taking a couple of minutes to register your account now.
See upgrades in your document processing immediately after you open your DocHub account. Save your time on editing with our single platform that will help you become more efficient with any file format with which you need to work.
(light instrumental music) - Good morning, everybody. My name is Sandra Narayanan, Im a stroke and interventional neurologist at University of Pittsburgh Medical Center. And its my pleasure today to be interviewing Dr. Yvo Ross, who is Professor of Acute Neurology, and Head of the Department at Amsterdam University Medical Center. He initiated a dedicated acute brain unit in the emergency department to improve door-to-needle times, and this ultra early treatment system formed the basis for the endovascular therapy set up at AMC Amsterdam, and the blueprint for the treatment arm of the MR CLEAN trial. Professor Ross initiated and was PI of the clot MR CLEAN study published in the New England Journal of Medicine, which demonstrated the treatment effects are sustainable over time, and are also cost-effective. He, along with Dr. Charles Majoie are co-PIs of the MR CLEAN-NO IV trial, which we will be discussing here shortly, within the Dutch Contrast Consortium, which stands for a coll